PSMD14-YAP1

Yunfei Wu1, Zhijie Xu1, Runzhe Wang1

  • 1Department of Urology, The First Affiliated Hospital, School of Medicine, Zhejiang University, Hangzhou 310009, China; Zhejiang Engineering Research Center for Urinary Bladder Carcinoma Innovation Diagnosis and Treat-ment, Hangzhou 310024, China.

Translational oncology
|March 23, 2025
PubMed
概括

脱化酶 (DUBs) 驱动膀癌的进展. PSMD14是一种新的DUB,通过稳定核素 (NCL) 和YAP1促进恶性瘤,为膀癌提供潜在的治疗点.